Baylor Scott & White Research Institute, the research arm of Baylor Scott & White Health, is bringing clinical trials online at an unprecedented pace in response to COVID-19. A COVID-19 therapeutic task force of more than 20 multidisciplinary researchers positioned across the state of Texas has been putting their expertise in infectious disease, cardiology, immunology, molecular biology, and other specialties together to explore research opportunities for experimental prevention and treatment options and to develop investigator-initiated studies.

Baylor Scott & White Health’s Glenda Tanner Vasicek Cancer Treatment Center (VCTC) – Temple announces construction of a new radiation oncology facility that will benefit Central Texas patients being treated for cancer. With new radiation treatment equipment and more room for procedures, the facility will be able to treat up to 70 patients per day.

Baylor Scott & White All Saints Medical Center Fort Worth and the TCU and UNTHSC School of Medicine will be collaborating on an Accreditation Council for Graduate Medical Education (ACGME)-accredited physician resident training program that will eventually train more than 150 physicians annually. The collaboration will be a boon not only for the medical community in Fort Worth, but also for residents of North Texas as it helps to address a growing need for physicians in the Fort Worth area.

Baylor University Medical Center at Dallas, a part of Baylor Scott & White Health, is the first hospital in Dallas-Fort Worth designated as a Level IV maternal care center, the highest possible designation by the Texas Department of State Health Services.

Baylor Scott & White Health, the largest not-for-profit health system in Texas, opened its newest full-service hospital today in Austin. Austin, located at 5251 W. U.S. Highway 290, Austin, TX 78735, becomes the System’s first hospital within Austin city limits. In addition to the hospital, a multi-specialty medical clinic will be located on the same campus as part of a comprehensive model of care.

Baylor Scott & White Health is proud to have been nationally ranked among the “Top 10” on VIQTORY’s 2020 list of Military Friendly® Employers in the category for Government/Non-Profit organizations. Baylor Scott & White, ranked #7, was recognized for exceeding benchmark standards for Military Friendly® designation within six broad categories that address recruiting, hiring, retention, advancement, support and policy compliance.

A study published today in The New England Journal of Medicine found that in patients seen for heartburn unresponsive to treatment with Proton Pump Inhibitors (PPIs), an extensive, systematic workup revealed truly PPI-refractory and reflux-related heartburn in only a minority of cases. In other words, most patients with heartburn unrelieved by PPIs did not have gastroesophageal reflux disease (GERD) causing the symptom. Furthermore, for the selected subgroup identified as having reflux-related, PPI-refractory heartburn, surgery that corrects reflux was significantly superior (67% success rate) to continued medical therapy (28% success rate).

Today marks the eighth birthday of Baylor Scott & White McLane Children’s Medical Center and the completion of the first phase of its expansion to better serve children in the System’s 30,000 square-mile Central Texas service area.

Kayla and Lance Edwards are excited to publicly announce the birth of their daughter Indy Pearl Edwards through a landmark uterus transplant clinical trial at Baylor University Medical Center at Dallas, a part of Baylor Scott & White Health.

Baylor Scott & White Health, the largest not-for-profit healthcare system in Texas, opened its newest full-service hospital. Baylor Scott & White Medical Center – Buda, the System's first medical center in Hays County, is located at 5330 Overpass Road and is open 24 hours a day, 7 days a week.

Warriors Research Institute, a Baylor Scott & White Research Institute center, has been awarded a $500,000 grant from the Texas Veterans Commission Fund for Veterans’ Assistance that will help expand evidence-based mental health treatment to Texas veterans and their families. The treatment is available at no cost to veterans and family members regardless of discharge status.

Baylor University Medical Center at Dallas, a part of Baylor Scott & White Health, today announces that a third family has welcomed a baby after the mother participated in a landmark uterus transplant clinical trial.

Baylor Scott & White Health now offers a new, more convenient prescription pickup option for patients. Baylor Scott & White Pharmacy kiosks, which are located on medical centers throughout the healthcare system’s service area, are now being installed offsite to make filling prescriptions easier for more patients.

Baylor Scott & White Health leads the state of Texas in the number of accolades earned in U.S. News & World Report's "America's Best Hospitals" 2018-19 list, released today. Sixteen Baylor Scott & White hospitals were recognized, with two receiving national rankings.

More than 500 men who suffered with problems urinating due to an enlarged prostate have undergone holmium laser enucleation of the prostate (HoLEP), a minimally invasive procedure, at Scott & White Medical Center – Temple. This innovative urological procedure provides much-needed relief for men with a prostate enlargement, also known as benign prostatic hyperplasia (BPH), a condition that can prevent the bladder from emptying properly and could lead to kidney damage or failure.

Baylor Scott & White Health and Select Medical today announced an expansion of their joint venture into the Austin area with the acquisition of a 36-bed inpatient rehabilitation hospital in Lakeway, Texas, that will be operated under the name Baylor Scott & White Institute for Rehabilitation – Lakeway. The transaction is expected to close by July 1, 2018.

Baylor Scott & White McLane Children’s Medical Center and Clinics care for children and their families with compassion and quality care, and the newest four-legged staff member, Lorenzo, plans to do the same by motivating and supporting patients with gentle snuggles and a warm heart. Lorenzo, a certified facility dog from Canine Companions for Independence (CCI), who will assist the medical center’s Child Life Program and becomes the first facility dog from CCI to join a Texas pediatric (children's) hospital.

Scott & White Medical Center – Temple, part of Baylor Scott & White, is one of 15 U.S. hospitals selected to participate in the American College of Cardiology Patient Navigator Program: Focus MI Quality Campaign as a “Diplomat Hospital.”
This is an expanded version of the original Patient Navigator Program launched in 2013. Scott & White – Temple was one of 35 pioneering hospitals chosen to provide personalized services to heart disease patients to help them avoid a quick return to the hospital.

Baylor Scott & White Health – the largest not-for-profit healthcare system in Texas — announced several key additions to its executive leadership team. All four women bring a wealth of experience to their new positions and will play vital roles in shaping the strategic future of the system.

Skin-to-skin contact with mom helps newborns at risk of neonatal hypoglycemia stay out of the neonatal intensive care unit, according to a new study by clinicians at Baylor Scott & White Medical Center — McKinney.

Researchers at Baylor Scott & White Research Institute reveal curcumin has potential to overcome chemoresistance in pancreatic ductal adenocarcinoma, a common but aggressive form of cancer in the pancreas.

A new clinical trial at Baylor Scott & White Research Institute is exploring a novel treatment option for patients with multiple myeloma, a type of cancer formed in bone marrow plasma cells that is considered incurable.

New research detailing the molecular mechanisms involved in the breakdown of the soft tissue discs of the spine has the potential to help millions suffering the debilitating back pain, and may provide opportunities for advanced, minimally invasive treatments.

Aspirin has long been used to help prevent and manage heart disease. However, researchers at Baylor Scott & White Research Institute have discovered another potential benefit –- protection against Barrett’s esophagus, a disorder that causes damage to the esophagus from long-term acid reflux disease, and can help lower associated cancer risk.

Researchers at Baylor Institute for Rehabilitation and Baylor Scott & White Research Institute received a grant to participate in a nationwide study to improve post-acute care for patients who have suffered a traumatic brain injury.

Colorectal cancer patients with certain genetic backgrounds may benefit more from taking aspirin to prevent cancer reoccurrence, based on a study conducted by researchers at the Baylor Scott & White Health Research Institute.
The study, published this month in Cancer Prevention Research, examined how aspirin influences the growth of cultured colorectal cancer cells with a variety of different mutational backgrounds and aimed to explain why aspirin is more effective in some patients than others.

A review article in Clinical Cancer Research by Investigators from Baylor Scott & White Research Institute examines the potential for microRNAs – molecules that regulate gene expression – to detect gastrointestinal cancer in blood and other bodily fluids, known as a liquid biopsy.

A new study conducted by researchers at Baylor University Medical Center at Dallas identified a key interaction between Fusobacterium nucleatum, a bacteria commonly linked to gum disease, and a specific microRNA gene regulator in the gut that led to tumor growth in the colon.

One of last year's major achievements in clinical cancer research and care was a study comparing open and laparoscopic surgery led by James Fleshman, MD, colorectal surgeon on the medical staff and chief of surgery at Baylor University Medical Center.

Baylor Heart and Vascular Services at Fort Worth on Tuesday, November 15, became the first program in Texas to implant the only FDA-approved device designed to prevent blood clots from entering the brain by sealing a hole in the heart. The device is designed to help reduce the risk of recurrent cryptogenic strokes in patients diagnosed with a patent foramen ovale (PFO) – a small opening between the upper chambers of the heart.

Baylor Scott & White Research Institute will be home to one of four new Centers of Research Translation, or CORTs. National Institute of Arthritis and Musculoskeletal and Skin Diseases will fund $8.5 million over five years toward the center’s research, which aims to better understand the development of severe lupus in children and could ultimately lead to new personalized treatments.

A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology.